POSTED BY HUGH THOMPSON | 10 MAY 2024 MHRA issues its first medicinal product approval through the International Recognition Procedure The MHRA has promised a pro-innovation agenda for life sciences. The first approval of a medicinal product through the International Recognition Procedure is a welcome step for industry and patients alike. Read more Share this article Bookmark this page 2 min read
POSTED BY NICOLA HOLMES | 13 FEBRUARY 2024 Disparaging the competition? Recent competition law investigations in the life sciences sector highlight the need for caution when making statements about a competitor's products. Share this article Bookmark this page 3 min read
POSTED BY MARK PEARCE | 5 FEBRUARY 2024 Intellectual property issues around use of AI in life sciences AI is increasingly being used across many sectors, including life sciences. Intellectual property expert Mark Pearce considers some of the current issues, around both protection of innovations and use of data resources. Share this article Bookmark this page 4 min read
POSTED BY ISABEL TEARE | 1 FEBRUARY 2024 An update to the pharma industry's ABPI Code A review of the ABPI Code for the promotion of medicines in the UK is undergoing a review, with the changes expected to take effect before the end of 2024. Share this article Bookmark this page 2 min read
POSTED BY ISABEL TEARE | 6 OCTOBER 2023 Europe's Unified Patent Court is up and running How are the early months of Europe's Unified Patent Court going? We look at some of the initial trends and issues, with a focus on life sciences litigation. Share this article Bookmark this page 3 min read
5 OCTOBER 2023 International Recognition Procedure for fast-track approval of medicines An overview of the UK's new International Recognition Procedure for the fast-track approval of medicines. Share this article Bookmark this page 3 min read
POSTED BY ISABEL TEARE | 7 SEPTEMBER 2023 Horizon Europe - the UK’s associate membership is agreed Agreement is reached for the UK to join Horizon Europe as an associate member. Share this article Bookmark this page 2 min read
POSTED BY ISABEL TEARE | 16 AUGUST 2023 More time to comply with EU medical device reforms - is it enough? We consider the EU's extension of periods for compliance with its regulatory reforms for medical devices, and whether these will be enough for producers and notified bodies to deal with all legacy devices. Share this article Bookmark this page 3 min read
POSTED BY ISABEL TEARE | 18 JULY 2023 A strong UK commitment to the life sciences sector: a package of support and a refresh of clinical trials UK Government is pushing forward with a package of regulatory reforms, streamlining of systems and a programme of targeted support to boost the life sciences sector. Share this article Bookmark this page 3 min read
POSTED BY ISABEL TEARE | 18 JULY 2023 The EU AI Act - time to take note As the EU AI Act moves to completion innovators should take note. It will affect all AI systems that will be put to use in the EU. We consider the legislation from a life sciences sector perspective. Share this article Bookmark this page 4 min read
Subscribe Receive blog alerts via email from our leading team of legal experts Register Visitor Login